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Smokers frequently suffer from impaired fracture healing often due to poor bone quality and
stability. Cigarette smoking harms bone cells and their homeostasis by increased formation of
reactive oxygen species (ROS). The aim of this study was to investigate whether Quercetin, a
naturally occurring antioxidant, can protect osteoblasts from the toxic effects of smoking. Human
osteoblasts exposed to cigarette smoke medium (CSM) rapidly produced ROS and their viability
decreased concentration- and time-dependently. Co-, pre- and postincubation with Quercetin
dose-dependently improved their viability. Quercetin increased the expression of the anti-oxidative
enzymes heme-oxygenase- (HO-) 1 and superoxide-dismutase- (SOD-) 1. Inhibiting HO-1 activity
abolished the protective effect of Quercetin. Our results demonstrate that CSM damages human
osteoblasts by accumulation of ROS. Quercetin can diminish this damage by scavenging the
radicals and by upregulating the expression of HO-1 and SOD-1. Thus, a dietary supplementation
with Quercetin could improve bone matter, stability and even fracture healing in smokers.
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1. INTRODUCTION
Bone, as one of the most metabolically active tissues of the body, undergoes a constant and complex process
of remodeling throughout life. This remodeling cycle is composed of four sequential phases. Activation
precedes resorption followed by reversal and formation. Osteoblasts in particular play a key role in this
cycle. Derived from osteoprogenitor cells they rise from self-renewing, pluripotent stem cells. Their main
function is to produce new bone matrix and, as osteocytes, to support the bone structure itself. Impairment
of osteoblasts thus can lead to several dysfunctions. Among them is delayed fracture healing, osteoporosis
or an increased rate of pseudarthrosis.
Tobacco smoking is a major health risk. Cigarette smoke consists of more than 6000 molecular
species, of which over 150 are known toxic compounds contributing to the pathogenesis of a variety of
diseases, for example, cancer and cardiovascular and pulmonary diseases [1]. As those diseases account
for up to 20% of precocious deaths in the USA, they are focus of many research groups. Upon that, in the
past years several studies have described the negative effects of cigarette smoke on bone [2, 3]. Smoking
is associated with delayed fracture healing, reduced bone density, alterations in bone mineral content, and
osteoporosis [4, 5]. Recent data suggest that toxins contained in cigarette smoke may not only initiate and
exacerbate tissue injury but also impair reparative processes via the initiation of inﬂammatory responses
[6]. Tissue destruction may be exerted either through direct toxic effects (e.g., DNA damage), altered gene
regulation, or indirectly through increased oxidative stress [1, 3, 7]. In our continuously ageing society this
represents a major health problem, as quality of life is signiﬁcantly reduced by prolonged hospital stays and
reduced mobility.
Flavonoids are widely distributed in sources of vegetal origin (fruits, seeds, roots, ﬂowers, tea, or
wine). They are known to have multiple beneﬁcial biological, pharmacological, and medicinal properties
including anti-inﬂammatory, antimutagenic, antineoplastic, and cytoprotective effects [8]. A fundamental
property of these molecules, responsible for many of their positive effects, is the antioxidant capacity. This
is due to the presence of a series of structural characteristics that allow them to quelate ions of transition
metals such as Fe2+,C u 2+ or Zn2+ and to catalyze the electron transport. Another important function is to
scavenge reactive oxygen species (ROS) like superoxide anion, oxygen singlet, and lipidic peroxyradicals
or to stabilize free ROS by means of hydrogenation or formation of complexes with oxidizing species [8].
Accordingly recent reports indicate the capacity to reduce and prevent bone loss and show positive effects
on osteoblast and osteoclast activities [9, 10]. Among the more than 4000 varieties of the ﬂavonoid family,
Quercetin is an important member. It has been shown to reduce oxidative stress-dependent damage not
only in vitro (e.g., ethanol-treated primary human hepatocytes) [11, 12] but also in vivo in rats exposed to
methyl-mercury [13]. Moreover, recent evidence suggests that various ﬂavonoids may positively inﬂuence
negative effects of cigarette-associated tissue damage in humans [14].
The purpose of the here presented study was to determine whether Quercetin proved to exert a
protective effect in osteoblasts exposed to CSM. In addition, this study’s aim was to analyze the possible
activation of antioxidative pathways by the ﬂavonoid Quercetin in osteoblasts.
2. MATERIALS AND METHODS
Dulbecco’s phosphate-buffered saline (DPBS) and cell culture medium and supplements were obtained
from PAA Laboratories (C¨ olbe, Germany); antibodies from Santa Cruz Biotechnology (Heidelberg,
Germany); and chemicals if not stated differently from Sigma (Munich, Germany).
2.1. Isolation and Culture of Primary Human Osteoblasts
Primary human osteoblasts were isolated from femur heads of patients undergoing total hip replacement.
The isolation was approved by the ethical committee from the “Klinikum rechts der Isar”, Technische
Universit¨ at M¨ unchen. Brieﬂy, cancellous bone was removed mechanically from the femur head and washed
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3–5 times with DPBS followed by 1h incubation at 37◦C with an equal volume of digestion buffer (DPBS,
0.07% collagenase II-Biochrom AG, Berlin, Germany). After digestion, cancellous bone was washed
with culture medium (MEM/Ham’s F12, 10% FCS, 2mM L-glutamine, 100U/mL penicillin, 100μg/mL
streptomycin, and 50μM L-ascorbate-2-phosphate, 50μM β-glycerol-phosphate). Wash fraction was
transferred to cell culture ﬂasks to allow adherence of cells. Medium was changed every 4-5 days [15].
Osteoblasts were cultured and expanded until passage 3, where a pure population of osteoblasts, negative
for CD14 and CD45 and positive for CD90 and CD105, was reached (ﬂow cytometry). Then cells were
plated for the experiments (20,000cells/cm2).
2.2. Generation of CSM
CSM was prepared from commercially available cigarettes (Marlboro, Philip Morris, Munich, Germany), as
suggested by the Federal Trade Commission (FTC) and the International Organisation for Standardisation
(ISO 10362-2). Brieﬂy, the ﬁlter was removed and cigarettes were placed in a standard gas washing
bottle (Lenz Laborglas GmbH & Co.KG, Wertheim, Germany), subjected to negative pressure by using
a peristaltic pump [16]. Here 3 cigarettes were bubbled through 25mL of DMEM for 15min at a rate of
1puff/min, each puff lasting for 2 seconds. The freshly prepared CSM was ﬁltered (0.22μm ﬁlter, Sarstedt,
N¨ urnberg, Germany) before use. The concentration of CSM was determined and normalized by its optical
density at 320nm (OD320) in a plate reader (BMG Labtech, Offenburg, Germany).
2.3. Determination of ROS
After washing cells twice with DPBS they were incubated with 10μM2  ,7 -dichlorﬂuorescein-diacetate in
serum-free culture medium for 30min at 37◦C. After washing with DPBS the cells were stimulated with the
smoke extract. After 15min the ﬂuorescence intensity (ex/em = 485/520nm) was quantiﬁed using a plate
reader.
2.4. Viability Measurement
Viability was determined by resazurin conversion. Brieﬂy, after stimulation 1/10 volume of a 0.025% (w/v)
resazurin solution (in DPBS) was added to the cells. After 1h incubation at 37◦C ﬂuorescence intensity was
measured (ex/em = 540/590nm) using a plate reader and corrected to background control (solvent mixture
without cells). Viability is given as % of control (untreated cells).
2.5. Western Blot
Cells were lysed in ice-cold RIPA lysis buffer (50mM Tris; 250mM NaCl; 2% Nonidet-P40; 2.5mM
EDTA; 0.1% SDS; 0.5% DOC; complete mini protease inhibitor and phosphatase inhibitor used according
to the manufacturer’s speciﬁcations; pH = 7.2). Protein concentration was determined by micro-Lowry.
30μg total protein was separated by SDS PAGE and transferred to nitrocellulose membranes (Carl Roth,
Karlsruhe, Germany).
2.6. Statistics
Results are expressed as mean ± SEM of at least 3 independent experiments (N ≥3) measured as triplicates
or more (n ≥ 3). Data sets were compared by one-way analysis of variance followed by Bonferroni’s
multiple comparison test (GraphPad Prism Software, El Camino Real, USA). P < 0.05 was taken as
minimum level of signiﬁcance.
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FIGURE 1: CSM damages primary human osteoblasts in a time- and concentration-dependent manner. (a)
Primary human osteoblasts (N = 3, n = 6) were treated with concentrated CSM for 0, 1.5, 3, 6, 12, and
24h. After stimulation viability was determined by resazurin conversion. (b) The optical density of different
dilutions (0, 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100%) of CSM was determined at λ = 320nm (OD320).
(c) The same dilutions were tested for their toxic effect after 4h stimulation (EC50 ≈ 0.75 OD320). (d) After
15min CSM induces signiﬁcantly (P < 0.01 from 50% CSM on) the production of ROS in primary human
osteoblasts (N = 3, n = 4).
3. RESULTS
3.1. CSM Reduces Viability of Osteoblasts Time- and Concentration-Dependently
Primary human osteoblasts viability was determined after incubation for 0, 1.5, 3, 6, 12, and 24h with
concentrated CSM (N = 3, n = 6). Viability was reduced in a time-dependant manner, reaching 100%
toxicity after 12h and 50% toxicity ranging around 4h (Figure 1(a)). In continuation and to standardize
the experimental setup we identiﬁed the concentration of CSM when 50% toxicity was reached after a 4h
incubation period (N = 3, n = 6). This was obtained by a CSM with an OD320 of 0.8 (Figures 1(b) and
1(c)).
3.2. CSM Rapidly Induces ROS Formation in Osteoblasts Dose-Dependently
Primary human osteoblasts (N =3, n =4) loaded with DCFH-DA were exposed to different concentrations
of CSM. After 15min ROS formation was measured by an increase in ﬂuorescence intensity. A signiﬁcant
increase in ROS formation was observed starting at an OD of 0.5 (P < 0.01/Figure 1(d)).
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FIGURE 2: Quercetin reduces CSM-induced ROS production in primary human osteoblasts. (a) Pre-
incubation of primary human osteoblasts (N = 3, n = 4) with subtoxic concentrations of Quercetin (25, 50,
100μM) reduces the formation of ROS after 15min treatment with CSM (OD320 = 0.8). (b) Similar results
were observed during coincubation. ∗∗∗P < 0.001 compared to untreated cells, ◦◦◦P < 0.001 compared to
CSM-treated cells.
3.3. Quercetin Reduces ROS Production from CSM in Primary Human Osteoblasts
We determined the EC50/24h of Quercetin to be 280.1 ± 1.1μM(N =3, n =4). Coincubation with subtoxic
doses of Quercetin (25, 50, 100μM) signiﬁcantly reduced ROS formation dose-dependently (N = 3,
n = 4/Figure 2(a)). Concordantly, similar results were seen for pre-incubation with Quercetin (N = 3,
n = 4/Figure 2(b)).
3.4. Quercetin Protects Primary Human Osteoblasts from CSM-Dependent Damage
We measured viability of CSM-treated (OD320 = 0.8) primary human osteoblasts after 4h pre-, co-, and
post-incubation with subtoxic concentrations of Quercetin (25, 50, and 100μM). An improved viability
was achieved through all three setups showing the most beneﬁcial results for coincubation reaching nearly
100% survival at a concentration of 100μM Quercetin. Interestingly, post-incubation with Quercetin also
induced recovery of primary human osteoblasts up to 80% of untreated cells. Noteworthy, preincubation
established a similar protective effect with a cell survival of nearly 75% (Figure 3).
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FIGURE 3: Quercetin reduces CSM-induced cellular damage in primary human osteoblasts dose-
dependently. (a) Stimulation of primary human osteoblasts (N = 3, n = 4) for 4h with 25, 50, and 100μM
Quercetin is not toxic to the cells. (b) Pre-, (c) co-, and (d) postincubation with these subtoxic concentrations
of Quercetin protects primary human osteoblasts (N = 3, n = 4) from CSM-induced (OD320 = 0.8) cellular
damage. Viability was measured by resazurin conversion. Results are given as fractional survival [%]
compared to untreated cells. ∗∗P < 0.01, ∗∗∗P < 0.001 compared to CSM-treated cells.
3.5. Quercetin Induces Expression of HO-1 and SOD-1 in Human Osteoblasts
Primary human osteoblasts exposed to 100μM Quercetin for 4h were examined for expression of the anti-
oxidative enzymes HO-1 and SOD-1, the transcription factor pNrf2 and phosphporylation of ERK and
SAPK/JNK by Western blot. An increase in pNrf2, HO-1, and SOD-1 protein levels became evident when
stimulated with Quercetin. At the same time phosphorylation of ERK1/2 increased but not phosphorylation
of SAPK/JNK (Figure 4(a)).
3.6. Inhibition of HO-1 Reverses Protective Effects of Quercetin
We determined the EC50/24h of the HO-1 inhibitor zinc protoporphyrin (ZnPP9) to be 12.3 ± 1.1μM
(N = 3, n = 4). In order to investigate if the protective effect of Quercetin is dependent on HO-1 expression
we measured the survival of CSM-treated primary human osteoblasts after pre-, co-, and post-incubation
with 100μM Quercetin in the presence or absence of 10μM ZnPP9 (N = 3, n = 4). It became evident that
the presence of ZnPP9 diminished the protective effect of Quercetin (Figure 4(b)).
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FIGURE 4: Quercetin protects primary human osteoblasts from CSM-induced damage via upregulation of
anti-oxidative enzymes HO-1 and SOD-1. (a) Representative picture of a Western blot for pNrf2, HO-1,
SOD-1, pERK1/2, and pSAPK in primary human osteoblasts treated with or without 100μM Quercetin.
Quercetin induces the expression of HO-1 and SOD-1 and phosphorylation of pNrf2 and ERK1/2. GAPDH
was used as loading control. (b) The HO-1 inhibitor ZnPP9 (10μM) reduces the protective effect of
Quercetin (100μM/pre- and co-incubation) on primary human osteoblasts (N = 3, n = 4) treated with CSM
(OD320 =0 . 8 )f o r4 h .∗∗∗P < 0.001 compared to untreated cells; ◦◦◦P < 0.001 compared to CSM-treated
cells.
4. DISCUSSION AND CONCLUSIONS
Our results clearly demonstrate the toxic effects of CSM on primary human osteoblasts. An increase
in oxidative stress is related to osteoblasts cell death. According to recent experimental ﬁndings this
plays a key role in clinical observations such as delayed fracture healing, increased rate of osteoporosis,
or reduced bone mass [2–5]. Quercetin is one of the most frequently studied ﬂavonoids, and it exerts
beneﬁcial but also deleterious effects depending on the cell type [8–10]. There have been reports indicating
the inhibitory potential of Quercetin on osteoclasts via its estrogenic effect acting as a phytoestrogen in
rabbit long bones. Induction of osteoclasts apoptosis and antiresorptive actions is, concerning this matter,
attributable to Quercetin [10]. Pang and coworkers complement these ﬁndings [9]. Despite these results the
precise molecular mechanisms of Quercetin remain uncertain. Nam and colleagues for example showed
that Quercetin at a concentration as low as 20μM induced apoptotic cell death in the mouse osteoblastic
cell line MC3T3-E1 in an ERK1/2-dependent manner [17]. These data are at variance with previous reports
in which Quercetin does not induce cell death in rat calvaria osteoblastic cells [18], MC3T3-E1 cells [19],
and MG-63 human osteoblastic cells [20]. In our model Quercetin induced phosphorylation of ERK1/2;
however, reduced cell viability was only observed after 24h exposure at concentrations above 200μM.
Highlighting the discrepancy to the ﬁndings of Nam and colleagues we obtained signiﬁcant protective
effects of Quercetin at concentrations comparable to physiological relevant plasma levels. Furthermore,
the ability to reduce ROS was not observed at concentrations below 50μM in osteoclasts as described by
Wattel and coworkers [10]. However, even concentrations as low as 25μM of Quercetin protect primary
human hepatocytes from ethanol-induced damage [11, 12].
Nevertheless, despite our observed positive effects, it is mandatory to remain cautious when
analyzing its clinical potential. There have been reports of DNA damage at Quercetin concentrations
of >30μM[ 21]. Furthermore, Quercetin concentrations exceeding 75μM can have some intrinsic
cytotoxicityinculturedrenaltubularcells[22].Highdosesmayevenexertgenotoxiceffects[23].Moreover,
it has been reported that Quercetin at concentrations >50μM is able to participate in the oxidation of
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NADPH in liver cells, shifting the cellular conditions to a more oxidized state [24]. An additional aspect is
the limited bioavailability of ﬂavonoids, due to its low absorption and rapid elimination [8]. Thus, absorbed
Quercetin becomes rapidly conjugated in the human body. The group of Chattopadhyay could show that
a Quercetin C-glucoside improved bone formation rate and trabecular microarchitecture in ovariectomized
rats better than Quercetin itself [25, 26].
Using the here presented in vitro model we emphasized the potent protective effect of Quercetin
in osteoblasts in pre-, co-, and post-incubation conditions. Our data is in concordance with recent
epidemiological and experimental ﬁndings demonstrating positive effects of ﬂavonoids on bone. M¨ uhlbauer
and colleagues have shown that several vegetables signiﬁcantly inhibited bone resorption in rats
[27]. Highlighting ﬂavonoids beneﬁcial effects Horcajada-Molteni reduced bone resorption in vivo in
ovariectomized rats through rutin, a Quercetin glycoside [28]. Furthermore, Arjmandi and coworkers
showed that dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis [29].
Beside this experimental evidence, a recent paper by Bohn and coworkers clearly suggests that cellular
stress defense is positively modulated by antioxidant-rich food in human cigarette smokers [14].
We have shown that Quercetin can induce the antioxidant enzyme HO-1 via its transcription factor
pNRF2, thus protecting primary human osteoblasts in the preincubation setting. A similar mechanism has
been observed in primary human hepatocytes [11, 12]. This antioxidant activity primes the cells against
radicals possibly causing cell death. This appears to be of great interest in preoperative treatment of patients
in order to diminish stress-related toxicity. Flavonoids directly reduce oxidative stress in cells by their
structural properties as radical scavengers, most probably related to the phenolic hydroxyl groups attached
to the ring structures. This, in combination with upregulation of HO-1, might explain the more protective
effects of Quercetin during the co- and postincubation setup. This elementary function could be used to
treat patients already exposed to elevated ROS levels, since ROS have been suggested to be involved in the
pathogenesis of bone loss-related diseases [30].
In summary, our results show that Quercetin, a natural ﬂavonoid widely distributed in a healthy
human diet, is able to reduce ROS formation. It aids the antioxidant network in compensating the elevated
redox imbalance in patients with increased ROS levels such as smokers. Furthermore, Wattel et al. showed
inhibitory effects of Quercetin on bone resorption by inhibiting osteoclast activity [10].
In combination with these ﬁndings our data suggest that Quercetin may not only exert a beneﬁcial
effect in bone remodeling via its inﬂuence on osteoclasts, but also via a protective effect on osteoblasts.
Therefore, Quercetin might be used in not only supporting bone regeneration in smokers but also
strengthening the bone metabolism in different pathogenesis. Quercetin can support the maintenance of
skeletal integrity while buffering the toxic effect of CSM. Further research in this ﬁeld (e.g., human trials)
is mandatory to elucidate possible therapeutic strategies.
ABBREVIATIONS
CSM: Cigarette smoke medium
ROS: Reactive oxygen species
HO-1: Heme-oxygenase-1
SOD-1: Superoxide-dismutase-1.
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